雅虎香港 搜尋

登入

搜尋結果

  1. 焦點新聞

    查看全部

  2. www.cdc.gov › coronavirus › 2019-ncovmRNA COVID-19 疫苗 如何發揮作用 - Centers for Disease ...

    希望接種疫苗？了解 COVID-19 病毒。新型冠狀病毒就是導致 COVID-19 的病毒，命名來自表面突起的 棘冠，其稱為刺突蛋白。此等 刺突蛋白是疫苗的理想目標。mRNA 是甚麼？信使 RNA（mRNA）是指示身體 產生蛋白質的基因材料。疫苗內有甚麼？疫苗以

  3. www.cdc.gov › coronavirus › 2019-ncovmRNA COVID-19 疫苗 是如何起作用的 - Centers for Disease ... 簡

    疫苗里面有什么？这种疫苗是由信使RNA包裹在 一种涂层中制成的，这种涂层 使传递更容易，并防止身体对其 造成损伤。疫苗如何起作用？疫苗中的mRNA会教您的细胞如 何复制刺突蛋白。如果您以后接 触到真正的病毒，您的身体就会 识别它，知道如何抵御

  4. www.cdc.gov › vaccines › hcpACIP COVID-19 Vaccine Recommendations | CDC

    • Overview
    • CURRENT COVID-19 Vaccine Recommendations
    • ARCHIVED COVID-19 Immunization Publications

    See Clinical Considerations for Use of COVID-19 Vaccines

    在「cdc.gov」查看更多資訊

    •MMWR, October 20, 2023, Vol 72(42);1140–1146

    Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

    •Print version [7 pages]

    •See also:

    •Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Updated COVID-19 vaccine (2023-2024 Formulation) | CDC

    •EtR framework for Use of an Updated (Monovalent XBB Containing) COVID-19 Vaccine Under an Emergency Use Authorization | CDC

    在「cdc.gov」查看更多資訊

    For your convenience, these archived publications can be used for historical and research purposes.

    •MMWR, June 16, 2023, Vol 72(24);657–662

    Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023

    •Print version [6 pages]

    •MMWR, November 11, 2022, Vol 71(45); 1436-1441

    Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022 | MMWR (cdc.gov)

    在「cdc.gov」查看更多資訊

  5. www.cdc.gov › coronavirus › 2019-ncovVaccines for COVID-19 | CDC

    2024年4月23日 · Print. On June 27, 2024, the CDC Director adopted the ACIP’s recommendations for use of 2024–2025 COVID-19 vaccines in people ages 6 months and older as approved or authorized by FDA. The 2024–2025 vaccines are expected to be available in fall 2024.

  6. www.cdc.gov › indexCenters for Disease Control and Prevention | CDC

    CDC is the nation's leading science-based, data-driven, service organization that protects the public's health. CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. About CDC. Organization and Mission. Leadership.

  7. www.cdc.gov › coronavirus › 2019-ncovCoronavirus Disease 2019 (COVID-19) | CDC

    2024年3月15日 · Find links to guidance and information on all topics related to COVID-19, including the COVID-19 vaccine, symptom self-check, data, and other topics.

  8. www.cdc.gov › coronavirus › 2019-ncovMyths and Facts about COVID-19 Vaccines | CDC

    Getting a COVID-19 vaccine is a safer and more dependable way to build immunity to COVID-19 than getting sick with COVID-19. FACT: COVID-19 vaccination causes a more predictable immune response than an infection with the virus that causes COVID-19. COVID-19 can cause severe illness or death.